Abstract
Decision letter: mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have